SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Interim Management Statement

25 Oct 2013 07:00

RNS Number : 3576R
Elementis PLC
25 October 2013
 



 

 

Elementis - Interim Management Statement

 

Elementis plc (ELM.L, "Elementis" or "the Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 30 September 2013.

 

Commenting on the Group's performance Group Chief Executive, David Dutro, said:

"Elementis is pleased to report another resilient performance in spite of an economic background where growth is turning out to be slower than generally anticipated. The Group's strategy of creating its own growth opportunities, combined with its strong, diverse market positions and a return to more normal trading patterns in oilfield drilling are the key drivers of the Group's 12 per cent sales growth in the current quarter, compared to the same period last year. The integration of the Group's two recent acquisitions, Watercryl in Brazil and Hi-Mar in the US, is progressing well and the second and final phase of our new coatings additives plant in North America is well underway. These investments strengthen the broad geographic presence and enhance the Group's exciting market positions and will support further growth over the medium term."

 

 

Specialty Products sales improved by 15 per cent, or 8 per cent excluding acquisitions and currency.

 

· In coatings, sales in North America were higher by 12 per cent, mainly due to the acquisition of Hi-Mar earlier in the year. In Asia Pacific, sales increased by 11 per cent as the business continued to benefit from its market position in China, experiencing strong demand from local high-end industrial markets. Latin American sales increased by 68 per cent, driven by the acquisition of Watercryl in September 2012, and good progress is being made in expanding Watercryl sales outside of Brazil. In Europe, underlying economic conditions continue to be subdued as headline sales improved by 3 per cent, with currency contributing 4 per cent.

 

· In personal care, the business continued to benefit from the initiatives of a refocused management structure, with additional resources in new geographies and new product launches. As a result, sales improved by 16 per cent or 13 per cent excluding currency.

 

· Sales to the oil and gas drilling sector continued to demonstrate a sustained recovery following the impact of industry destocking in the latter part of 2012, maintaining the robust pace reported for the first six months of the year. Consequently, sales to this sector were at a similar level to the average quarterly sales in the first half of this year and 35 per cent ahead of the same period last year.

 

· Operating margin in the third quarter was similar to that reported for the first six months of the year as overall pricing and contribution margins remained stable.

 

As expected, following the planned maintenance shutdown in the early part of the year, Chromium trading patterns in the current quarter returned to more normal levels. Chromium sales in the quarter were 5 per cent ahead of the same period last year and at a similar level to the second quarter of the current year. As production volumes and plant utilisation returned to more normal levels, margins improved compared to the first half of the year and operating margin for the full year is expected to be in the range of 24-26 per cent. Consistent with our strategy of stable earnings and cash flow, we expect the performance of Chromium in the second half of 2013 will be similar to the second half of last year.

 

Cash flow continues to be a positive aspect of the Group's performance and it is anticipated that the end of year balance sheet will show a net cash balance of at least $30 million.

 

Overall we remain confident in the Group's ability to deliver growth that is in excess of the underlying economies in which it operates and expect our full year earnings per share to be in line with market expectations.

 

 

 

 

 

Enquiries:

Elementis + 44 (0) 207 408 9300

Brian Taylorson, Finance Director

  

FTI Consulting

 + 44 (0) 207 831 3113

Deborah Scott

Matthew Cole

  

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSOVROUARUAA
Date   Source Headline
29th Nov 201311:00 amRNSTotal Voting Rights
31st Oct 201311:00 amRNSTotal Voting Rights
25th Oct 20137:00 amRNSInterim Management Statement
16th Oct 20131:00 pmRNSAdditional Listing
1st Oct 20139:00 amRNSDirectorate Change
30th Sep 201311:00 amRNSTotal Voting Rights
6th Sep 20131:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20134:00 pmRNSBlocklisting Interim Review
30th Aug 20131:00 pmRNSTotal Voting Rights
28th Aug 201311:00 amRNSDirector/PDMR Shareholding
23rd Aug 20134:30 pmRNSHolding(s) in Company
2nd Aug 20134:00 pmRNSHolding(s) in Company
31st Jul 20134:01 pmRNSHolding(s) in Company
31st Jul 20134:00 pmRNSDirector/PDMR Shareholding
31st Jul 20131:00 pmRNSTotal Voting Rights
30th Jul 20137:00 amRNSInterim Results
22nd Jul 20137:00 amRNSDirectorate Change
3rd Jul 201311:00 amRNSHolding(s) in Company
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSAdditional Listing
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSHolding(s) in Company
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights
7th Nov 201211:00 amRNSAdditional Listing
31st Oct 20121:00 pmRNSTotal Voting Rights
26th Oct 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.